circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway
Gao, W; Guo, HN; Niu, M; Zheng, XW; Zhang, YL; Xue, XT; Bo, YF; Guan, XY; Li, ZX; Guo, YJ; He, L; Zhang, Y; Li, L; Cao, JM; Wu, YY
Wu, YY (corresponding author), Shanxi Med Univ, Shanxi Key Lab Otorhinolaryngol Head & Neck Canc, Hosp 1, Taiyuan 030001, Peoples R China.; Wu, YY (corresponding author), Shanxi Med Univ, Shanxi Prov Clin Med Res Ctr Precis Med Head & Ne, Hosp 1, Taiyuan 030001, Peoples R China.; Wu, YY (corresponding author), Shanxi Med Univ, Dept Otolaryngol Head & Neck Surg, Hosp 1, Taiyuan 030001, Peoples R China.; Wu, YY (corresponding author), Shanxi Med Univ, Key Lab Cellular Physiol, Minist Educ, Taiyuan 030001, Peoples R China.; Wu, YY (corresponding author), Shanxi Med Univ, Dept Biochem & Mol Biol, Taiyuan 030001, Peoples R China.
MOLECULAR CANCER, 2020; 19 (1):
